Cargando…
Comparison of pregnenolone sulfate, pregnanolone and estradiol levels between patients with menstrually-related migraine and controls: an exploratory study
BACKGROUND: Neurosteroids affect the balance between neuroexcitation and neuroinhibition but have been little studied in migraine. We compared the serum levels of pregnenolone sulfate, pregnanolone and estradiol in women with menstrually-related migraine and controls and analysed if a correlation ex...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989028/ https://www.ncbi.nlm.nih.gov/pubmed/33757421 http://dx.doi.org/10.1186/s10194-021-01231-9 |
_version_ | 1783668880962486272 |
---|---|
author | Rustichelli, Cecilia Bellei, Elisa Bergamini, Stefania Monari, Emanuela Lo Castro, Flavia Baraldi, Carlo Tomasi, Aldo Ferrari, Anna |
author_facet | Rustichelli, Cecilia Bellei, Elisa Bergamini, Stefania Monari, Emanuela Lo Castro, Flavia Baraldi, Carlo Tomasi, Aldo Ferrari, Anna |
author_sort | Rustichelli, Cecilia |
collection | PubMed |
description | BACKGROUND: Neurosteroids affect the balance between neuroexcitation and neuroinhibition but have been little studied in migraine. We compared the serum levels of pregnenolone sulfate, pregnanolone and estradiol in women with menstrually-related migraine and controls and analysed if a correlation existed between the levels of the three hormones and history of migraine and age. METHODS: Thirty women (mean age ± SD: 33.5 ± 7.1) with menstrually-related migraine (MM group) and 30 aged- matched controls (mean age ± SD: 30.9 ± 7.9) participated in the exploratory study. Pregnenolone sulfate and pregnanolone serum levels were analysed by liquid chromatography-tandem mass spectrometry, while estradiol levels by enzyme-linked immunosorbent assay. RESULTS: Serum levels of pregnenolone sulfate and pregnanolone were significantly lower in the MM group than in controls (pregnenolone sulfate: P = 0.0328; pregnanolone: P = 0.0271, Student’s t-test), while estradiol levels were similar. In MM group, pregnenolone sulfate serum levels were negatively correlated with history of migraine (R(2) = 0.1369; P = 0.0482) and age (R(2) = 0.2826, P = 0.0025) while pregnenolone sulfate levels were not age-related in the control group (R(2) = 0.04436, P = 0.4337, linear regression analysis). CONCLUSION: Low levels of both pregnanolone, a positive allosteric modulator of the GABAA receptor, and pregnenolone sulfate, a positive allosteric modulator of the NMDA receptor, involved in memory and learning, could contribute either to headache pain or the cognitive dysfunctions reported in migraine patients. Overall, our results agree with the hypothesis that migraine is a disorder associated with a loss of neurohormonal integrity, thus supporting the therapeutic potential of restoring low neurosteroid levels in migraine treatment. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s10194-021-01231-9. |
format | Online Article Text |
id | pubmed-7989028 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Milan |
record_format | MEDLINE/PubMed |
spelling | pubmed-79890282021-03-25 Comparison of pregnenolone sulfate, pregnanolone and estradiol levels between patients with menstrually-related migraine and controls: an exploratory study Rustichelli, Cecilia Bellei, Elisa Bergamini, Stefania Monari, Emanuela Lo Castro, Flavia Baraldi, Carlo Tomasi, Aldo Ferrari, Anna J Headache Pain Short Report BACKGROUND: Neurosteroids affect the balance between neuroexcitation and neuroinhibition but have been little studied in migraine. We compared the serum levels of pregnenolone sulfate, pregnanolone and estradiol in women with menstrually-related migraine and controls and analysed if a correlation existed between the levels of the three hormones and history of migraine and age. METHODS: Thirty women (mean age ± SD: 33.5 ± 7.1) with menstrually-related migraine (MM group) and 30 aged- matched controls (mean age ± SD: 30.9 ± 7.9) participated in the exploratory study. Pregnenolone sulfate and pregnanolone serum levels were analysed by liquid chromatography-tandem mass spectrometry, while estradiol levels by enzyme-linked immunosorbent assay. RESULTS: Serum levels of pregnenolone sulfate and pregnanolone were significantly lower in the MM group than in controls (pregnenolone sulfate: P = 0.0328; pregnanolone: P = 0.0271, Student’s t-test), while estradiol levels were similar. In MM group, pregnenolone sulfate serum levels were negatively correlated with history of migraine (R(2) = 0.1369; P = 0.0482) and age (R(2) = 0.2826, P = 0.0025) while pregnenolone sulfate levels were not age-related in the control group (R(2) = 0.04436, P = 0.4337, linear regression analysis). CONCLUSION: Low levels of both pregnanolone, a positive allosteric modulator of the GABAA receptor, and pregnenolone sulfate, a positive allosteric modulator of the NMDA receptor, involved in memory and learning, could contribute either to headache pain or the cognitive dysfunctions reported in migraine patients. Overall, our results agree with the hypothesis that migraine is a disorder associated with a loss of neurohormonal integrity, thus supporting the therapeutic potential of restoring low neurosteroid levels in migraine treatment. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s10194-021-01231-9. Springer Milan 2021-03-23 /pmc/articles/PMC7989028/ /pubmed/33757421 http://dx.doi.org/10.1186/s10194-021-01231-9 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Short Report Rustichelli, Cecilia Bellei, Elisa Bergamini, Stefania Monari, Emanuela Lo Castro, Flavia Baraldi, Carlo Tomasi, Aldo Ferrari, Anna Comparison of pregnenolone sulfate, pregnanolone and estradiol levels between patients with menstrually-related migraine and controls: an exploratory study |
title | Comparison of pregnenolone sulfate, pregnanolone and estradiol levels between patients with menstrually-related migraine and controls: an exploratory study |
title_full | Comparison of pregnenolone sulfate, pregnanolone and estradiol levels between patients with menstrually-related migraine and controls: an exploratory study |
title_fullStr | Comparison of pregnenolone sulfate, pregnanolone and estradiol levels between patients with menstrually-related migraine and controls: an exploratory study |
title_full_unstemmed | Comparison of pregnenolone sulfate, pregnanolone and estradiol levels between patients with menstrually-related migraine and controls: an exploratory study |
title_short | Comparison of pregnenolone sulfate, pregnanolone and estradiol levels between patients with menstrually-related migraine and controls: an exploratory study |
title_sort | comparison of pregnenolone sulfate, pregnanolone and estradiol levels between patients with menstrually-related migraine and controls: an exploratory study |
topic | Short Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989028/ https://www.ncbi.nlm.nih.gov/pubmed/33757421 http://dx.doi.org/10.1186/s10194-021-01231-9 |
work_keys_str_mv | AT rustichellicecilia comparisonofpregnenolonesulfatepregnanoloneandestradiollevelsbetweenpatientswithmenstruallyrelatedmigraineandcontrolsanexploratorystudy AT belleielisa comparisonofpregnenolonesulfatepregnanoloneandestradiollevelsbetweenpatientswithmenstruallyrelatedmigraineandcontrolsanexploratorystudy AT bergaministefania comparisonofpregnenolonesulfatepregnanoloneandestradiollevelsbetweenpatientswithmenstruallyrelatedmigraineandcontrolsanexploratorystudy AT monariemanuela comparisonofpregnenolonesulfatepregnanoloneandestradiollevelsbetweenpatientswithmenstruallyrelatedmigraineandcontrolsanexploratorystudy AT locastroflavia comparisonofpregnenolonesulfatepregnanoloneandestradiollevelsbetweenpatientswithmenstruallyrelatedmigraineandcontrolsanexploratorystudy AT baraldicarlo comparisonofpregnenolonesulfatepregnanoloneandestradiollevelsbetweenpatientswithmenstruallyrelatedmigraineandcontrolsanexploratorystudy AT tomasialdo comparisonofpregnenolonesulfatepregnanoloneandestradiollevelsbetweenpatientswithmenstruallyrelatedmigraineandcontrolsanexploratorystudy AT ferrarianna comparisonofpregnenolonesulfatepregnanoloneandestradiollevelsbetweenpatientswithmenstruallyrelatedmigraineandcontrolsanexploratorystudy |